Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 9, 2012, Pages 2499-2506

  Shen, Ai Jun ^a,b   Li, Dong Liang ^c   Cai, Xiao Jun ^a   Dong, Chun Yan ^a   Dong, Hai Qing ^a   Wen, Hui Yun ^a   Dai, Gong Hua ^b   Wang, Pei Jun ^a   Li, Yong Yong ^a  

^a TONGJI UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c FUZHOU GENERAL HOSPITAL   (China)

Author keywords

gadolinium; graphene oxide; hepatocarcinoma; magnetic resonance imaging; targeting

Indexed keywords

ANTICANCER DRUG; BIOMEDICAL APPLICATIONS; CANCER CELLS; CYTOTOXIC EFFECTS; DIMETHYLAMMONIUM; DOXORUBICIN HYDROCHLORIDE; FOLIC ACIDS; GRAPHENE OXIDES; HEPATOCARCINOMA; HYDROPHOBIC INTERACTIONS; IMAGING EFFICIENCY; IN-VITRO; IN-VIVO EXPERIMENTS; INTERMEDIATE PRODUCT; LOADING CAPACITIES; LOADING EFFICIENCY; MULTIFUNCTIONAL NANOCOMPOSITES; TARGETING; TREATMENT EFFICIENCY; TUMOR TARGETING;

CHLORINE COMPOUNDS; CYTOTOXICITY; DIAGNOSIS; GADOLINIUM; LOADING; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; ORGANIC ACIDS; SORPTION; TUMORS;

NANOCOMPOSITES;

DOXORUBICIN; FOLIC ACID; GRAPHENE OXIDE; GRAPHENE OXIDE POLY(ETHYLENE GLYCOL) FOLIC ACID GADOLINIUM DOXORUBICIN; NANOCOMPOSITE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CYTOTOXICITY; DRUG RELEASE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOXORUBICIN; DRUG CARRIERS; GADOLINIUM; GADOLINIUM DTPA; GRAPHITE; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NANOCOMPOSITES; OXIDES;

EID: 84864401581     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34148     Document Type: Article

References (28)

1. Sumer B, Gao JM,. Theranostic nanomedicine for cancer. Nanomedicine 2008; 3: 137-140.
2. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Brechbiel MW, Choyke PL,. Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase. Bioconjugate Chem 2003; 14: 1044-1047.
3. Lu ZR, Ye FR, Vaidya A,. Polymer platforms for drug delivery and biomedical imaging. J Control Release 2007; 122: 269-277.
4. Burger KNJ, Staffhorst RWHM, de Vijlder HC, Velinova MJ, Bomans PH, Frederik PM, de Kruijff B,. Nanocapsules: Lipidcoated aggregates of cisplatin with high cytotoxicity. Nat Med 2002; 8: 81-84.
5. Seo SB, Yang J, Hyung W, Cho EJ, Lee TI, Song YJ, Yoon HG, Suh JS, Huh YM, Haam S,. Novel multifunctional PHDCA/PEI nano-drug carriers for simultaneous magnetically targeted cancer therapy and diagnosis via magnetic resonance imaging. Nanotechnology 2007; 18: 475105-475112.
6. Feng LZ, Liu Z,. Graphene in biomedicine: opportunities and challenges. Nanomedicine 2011; 6: 317-324.
7. Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, Chen YS,. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 2008; 112: 17554-17558.
8. Sun XM, Liu Z, Welsher K, Robinson JT, Goodwin A, Zaric S, Dai HJ,. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008; 1: 203-212.
9. 4 nanoparticles hybrid for controlled targeted drug carriers. J Mater Chem 2009; 19: 2710-2714.
10. Yang K, Zhang S, Zhang G, Sun XM, Lee ST, Liu Z,. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010; 10: 3318-3323.
11. Jung I, Pelton M, Piner R, Dinkin DA, Stankovich S, Watcharotone S, Hausner M, Ruoff RS,. Simple approach for high-contrast optical imaging and characterization of graphene-based sheets. Nano Lett 2007; 12: 3569-3575.
12. Zhang L, Liang JJ, Huang Y, Ma YF, Wang Y, Chen YS,. Size-controlled synthesis of graphene oxide sheets on a large scale using chemical exfoliation. Carbon 2009; 47: 3365-3380.
13. Li SD, Huang L,. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008; 5: 496-504.
14. Luciani A, Olivier JC, Clement O, Siauve N, Brillet PY, Bessoud B, Gazeau F, Uchegbu IF, Kahn E, Frijia G, Cuenod CA,. Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. Radiology 2004; 231: 135-142.
15. Lim YT, Cho MY, Choi BS, Lee JM, Chung BH,. Paramagnetic gold nanostructures for dual modal bioimaging and phototherapy of cancer cells. Chem Commun 2008; 40: 4930-4932.
16. Rees O, Agarwal SK,. Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media. Clin Radiol 2010; 65: 636-641.
17. Kabalka G, Buonocore E, Hubner K, Moss T, Norley N, Huang L,. Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology 1987; 163: 255-258.
18. Raatschen HJ, Fu Y, Shames DM, Wendland MF, Brasch RC,. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-Based cascade polymer contrast agents: preclinical evaluations. Invest Radiol 2006; 41: 860-867.
19. Ali MM, Woods M, Caravan P, Opina AC, Spiller M, Fettinger JC, Sherry AD,. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. Chem Eur J 2008; 14: 7250-7258.
20. Zhang ZD, Shrikumar AN, Thomas JM,. Gadolinium meets medicinal chemistry: MRI contrast agent development. Curr Med Chem 2005: 12: 751-758.
21. Kamen BA, Capdevila A,. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 1986; 83: 5983-5987.
22. Garin-Chesa P, Campbell I, Saigo PE, Lewis JL Jr, Old LJ, Rettig WJ,. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol 1993; 142: 557-567.
23. Shen DW, Pastan I, Gottesman MM,. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res 1998; 58: 268-275.
24. Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen MM, Zalipsky S,. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies. Bioconjugate Chem 1999; 10: 289-298.
25. Park EK, Kim SY, Lee SB, Lee YM,. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 2005; 109: 158-168.
26. Hu HQ, Yu JH, Li YY, Zhao J, Dong HQ,. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery, J Biomed Mater Res B 2012; 100: 141-148.
27. Davis ID, Desai J,. Clinical use of therapies targeting tumor vasculature and stroma. Curr Cancer Drug Targets 2008; 8: 498-508.
28. Ehrlich P,. The Collected Papers of Paul Ehrlich, Vol. 3. Oxford: Pergamon Press; 1960. p 510.